Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
about
Molecular fingerprinting reflects different histotypes and brain region in low grade gliomas.The molecular biology of WHO grade I astrocytomasPerinatal (fetal and neonatal) astrocytoma: a reviewABT-263 enhances sensitivity to metformin and 2-deoxyglucose in pediatric glioma by promoting apoptotic cell deathThree paths to better tyrosine kinase inhibition behind the blood-brain barrier in treating chronic myelogenous leukemia and glioblastoma with imatinibNovel drugs in pediatric gliomas.Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters.Dapsone in dermatology and beyondLong-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.Institutional experience of paediatric high-grade central nervous system tumours: an analysis of 74 patients and review of the literature.Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas.Differences between brainstem gliomas in juvenile and adult rats.Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas.TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma.Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.Long-term epilepsy-associated tumors.Why dapsone stops seizures and may stop neutrophils' delivery of VEGF to glioblastoma.A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study.Preclinical evaluation of dipotassium bisperoxo (picolinato) oxovanadate V for the treatment of pediatric low-grade gliomas.Homozygous deletion of TNFRSF4, TP73, PPAP2B and DPYD at 1p and PDCD5 at 19q identified by multiplex ligation-dependent probe amplification (MLPA) analysis in pediatric anaplastic glioma with questionable oligodendroglial component.Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults.Molecular Basis of Pediatric Brain Tumors.Do patients with tuberous sclerosis complex have an increased risk for malignancies?Glioblastoma multiforme in a child with tuberous sclerosis complex.Chemical modulation of autophagy as an adjunct to chemotherapy in childhood and adolescent brain tumors
P2860
Q24288958-1AAA7CA2-C136-4944-B3A1-0D1353E51E94Q27010414-9A41FA23-D8D7-4A00-A6B0-09A085F85D85Q28076470-188232DC-46B6-46DE-B85E-C1CC37EEB024Q28488211-93AD157C-A7A1-451A-B14C-19B9C54A5E04Q33655352-BA256846-C72D-46C2-9E5C-D20F6CAFE7ECQ33685551-D0DC9D41-2FF2-449C-B4AE-820E3FD920C6Q34286305-EFE33D15-D301-4108-A946-909F7E31A809Q34390020-E842AAB9-CB67-47AB-95B7-10D793856244Q36261364-627DFEB2-FBD3-458E-A9D7-E7094A824BCAQ36942465-E377E3F2-C297-4BAD-AB5A-E5D10A23CD03Q37025863-A589C037-FBFC-4F1B-9534-7C0F6EC5F5D5Q37093507-6E70FADC-705F-4098-B840-65763E750E03Q37190159-34201123-1246-425C-85F6-60494630CF39Q37565322-42071A0B-DE54-451A-B5CB-C4D9DBFB3884Q37780775-8B41CA0E-5C48-4509-AB90-B7BB62E09DDCQ38002123-45E4EF79-CCF2-4052-8E30-0F43B8E5D4AAQ38007011-2E24B215-B3BF-45B1-BE2A-A8F24E98A574Q38086448-9799C4E4-7D61-4CA5-BEFC-4855A58F6600Q39117557-D1F50E86-AE47-442D-AE45-8E545CBFCB2DQ41898533-BDF74263-3BFD-45AD-80FE-8FD0164AEAB3Q42286853-3E758D5B-1093-41E3-A660-68D821D7F4ADQ48023007-9285820B-20E0-4026-8A77-B1A22530D78EQ53151688-F8132A72-987D-44F9-8603-EEFFA32F2029Q53517722-6617EDC5-38C7-4982-A1F6-12DE17FBAB4BQ59133202-847B3821-96E2-409D-A73B-AD4F23A50EA8
P2860
Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Paediatric high and low grade ...... on current and future therapy.
@en
Paediatric high and low grade ...... on current and future therapy.
@nl
type
label
Paediatric high and low grade ...... on current and future therapy.
@en
Paediatric high and low grade ...... on current and future therapy.
@nl
prefLabel
Paediatric high and low grade ...... on current and future therapy.
@en
Paediatric high and low grade ...... on current and future therapy.
@nl
P2860
P1476
Paediatric high and low grade ...... on current and future therapy.
@en
P2860
P304
P356
10.1080/02688690903158809
P577
2009-08-01T00:00:00Z